Bloomberg BusinessweekBloomberg Businessweek

Merck Makes Splash with Prometheus Acquisition

View descriptionShare
 

Bloomberg Intelligence Senior Pharmaceutical Analyst Sam Fazeli covers the news that Merck will buy Prometheus Biosciences for about $10.8 billion to bolster its research pipeline and strengthen its portfolio of autoimmune drugs. Irving Fain, CEO of Bowery Farming, discusses disruption in the vertical farming space. Honeycomb CEO Christine Yen talks about new funding for the observability cloud platform. And We Drive to the Close with Doug Ciocca, CEO at Kavar Capital.
Hosts: Carol Massar and Madison Mills. Producer: Paul Brennan.

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Bloomberg Businessweek

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and  
Social links
Follow podcast
Recent clips
Browse 5,275 clip(s)